Cascala Health Secures $8.6 Million Seed Funding to Improve Care Transitions
Transitions between care settings are among the riskiest points in healthcare. Each handoff between providers and systems can cause critical information to be lost, delayed, or misunderstood. Addressing this challenge, Cascala Health, a Boston-based startup, recently raised $8.6 million in seed funding. This round brings their total fundraising to $11.23 million.
The financing round was co-led by Flare Capital Partners and Eniac Ventures, with contributions from Digital Health Venture Partners, Omega Healthcare Investors, Tau Ventures, and Ziegler Linkage Fund.
Using AI to Streamline Care Transitions
Founded about a year ago, Cascala Health leverages artificial intelligence to improve the flow of information and communication among care teams during patient transitions. The platform detects risks in real time, allowing care providers to intervene before emergencies arise.
By identifying potential issues early, the solution helps reduce unnecessary hospital readmissions. According to CEO Matt Murphy, personalized interventions supported by the platform contribute to better patient recovery and higher satisfaction rates.
How Cascala's Platform Works
Cascala’s technology consolidates patient data from various sources—including hospital records, lab results, and clinician notes—and transforms it instantly into a concise, easy-to-understand summary. This helps keep patients, caregivers, providers, and risk-bearing organizations informed and aligned on the patient’s condition and care needs.
The platform delivers explainable and auditable outputs, ensuring clinicians can trust its recommendations. It supports collaboration with physicians and respects their control over care plans by complementing, not replacing, clinical judgment.
Target Customers and Cost Impact
Cascala focuses on fixing critical pain points in care transitions for accountable care organizations, risk-bearing providers, and health plans. By preventing readmissions and complications, the platform aims to reduce expensive hospital stays and emergency care, which are major cost drivers during transitions.
Positioning in the Market
Competitors include companies like Wellsky and Optum, which offer post-acute care coordination tools, as well as Innovaccer and Health Catalyst, known for broader population health data platforms. Cascala distinguishes itself by building its platform specifically for care transitions rather than general data management.
Murphy emphasizes that Cascala uses clinically responsible, AI-driven reasoning to generate actionable, context-aware insights—not just dashboards. While some electronic health record (EHR) systems provide tools for care transitions, those are limited to their own ecosystems.
Current Reach
Today, Cascala serves over 1,000 acute and post-acute facilities, impacting care for more than 300,000 patients.
Your membership also unlocks:
